HighTower Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

HighTower Advisors’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$409K	Hold	1,400	–	–	﹤0.01%	2929
2026 Q1	$233K	Sell	1,400 -2,110	-60%	-$346K	﹤0.01%	3369
2025 Q4	$559K	Buy	3,510 +1,000	+40%	+$137K	﹤0.01%	2521
2025 Q3	$235K	Sell	2,510 -1,500	-37%	-$106K	﹤0.01%	3229
2025 Q2	$228K	Buy	+4,010	New	+$213K	﹤0.01%	3170
2023 Q2	–	Sell	-227	Closed	-$23K	–	3572
2023 Q1	$23K	Buy	+227	New	+$30.8K	﹤0.01%	3138
2020 Q3	–	Sell	-208	Closed	-$247K	–	2619
2020 Q2	$247K	Buy	+208	New	+$180K	﹤0.01%	1855

Other funds holding LABU

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return

EFG

Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Simmons Bank Pine Bluff, Arkansas $1.75B AUM 33.61% 1-Year Est. Return

VPW

Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return

HHGA

Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Covestor London, United Kingdom $173M AUM 56.91% 1-Year Est. Return

HighTower Advisors's LABU Position: Q2 2026 in Review

HighTower Advisors held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q2 2026 at 1,400 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #2929.

HighTower Advisors first reported a position in LABU in Q2 2020 and has held it in 7 quarters since. The position peaked at $559K in Q4 2025. 17 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

HighTower Advisors held 1,400 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $409K as of Q2 2026.
HighTower Advisors left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q2 2026.
Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2929 holding.
HighTower Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2020 and has held it in 7 quarters since.
HighTower Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $559K in Q4 2025.
17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.